Detection of Helicobacter pylori and Chlamydia pneumoniae DNA in human coronary arteries and evaluation of the results with serologic evidence of inflammation

Saudi Medical Journal

Volumn 26, Issue 7, 2005, Pages 1068-1074

  Adiloglu, Ali K ^a,c   Ocal, Ahmet ^a   Can, Rabia ^b   Duver, Harun ^a   Yavuz, Turan ^a   Aridogan, Buket C ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b SSK Samsun Hospital   (Turkey)

^c NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; BACTERIAL DNA; C REACTIVE PROTEIN; IMMUNOGLOBULIN M; INTERLEUKIN 6; LIPID;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DNA DETERMINATION; ENDARTERECTOMY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; INTERNAL MAMMARY ARTERY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY; RISK ASSESSMENT; SEROLOGY; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL;

AGED; ANTIBODIES, BACTERIAL; APOLIPOPROTEINS B; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DNA, BACTERIAL; FEMALE; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED;

EID: 24044463872     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Johnston SC, Messina LM, Browner WS, Lawton MT, Morris C, Dean D. C-reactive protein levels and viable Chlamydia pneumoniae in carotid artery atherosclerosis. Stroke 2001; 32: 2748-2752.
2. Erren M, Reinecke H, Junker R, Fobker M, Schulte H, Schurek JO, et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999; 19: 2355-2363.
3. Robert S, Rosenson RS, Koenig WAM. Utility of inflammatory markers in the management of coronary artery disease. Am J Cardiol 2003; 92 (Suppl): 10i-18i.
4. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003; 169: 203-214.
5. Sniderman AD. How, when and why to use apolipoprotein B in clinical practice? Am J Cardiol 2002; 90 (Suppl): 48i-54i.
6. Ossei-Gerning N, Moayyedi P, Smith S, Braunholtz D, Wilson JI, Axon ATR, et al. Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Atherosclerosis 1997; 35: 120-124.
7. Blasi F, Denti F, Erba M, Cosentini R, Raccanelli R, Rinaldi A, et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 1996; 34: 2766-2769.
8. Tong CY, Sillis M. Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR. J Clin Pathol 1993; 46: 313-317.
9. Dowsett SA, Archila L, Segreto VA, Gonzalez CR, Silva A, Vastola KA, et al. Helicobacter pylori infection in indigenous families of Central America: serostatus and oral and fingernail carriage. J Clin Microbiol 1999; 37: 2456-2460.
10. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory Manual. 2nd ed. New York: Cold Spring Harbour Laboratory Press; 1989.
11. Farsak B, Yildirir A, Akyon Y, Pinar A, Oc M, Boke E, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol 2000; 38: 4408-4411.
12. Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 2001; 32: 385-391.
13. Chin B, Viira E, Tucker W, Fong W. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997; 96: 2144-2148.
14. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998: 316: 1130-1132.
15. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, et al. Serological evidence of an association of a novel Chlamydia TWAR, with coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983-986.
16. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430-436.
17. Jackson LA, Campbell LA, Kuo CC, Rodriguez DI, Lee A, Grayston JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 1997: 176: 292-295.
18. Ramirez JA. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis study group. Ann Intern Med 1996: 125: 979-982.
19. Prager M, Turel Z, Speidl WS, Zorn G, Kaun C, Niessner A, et al. Chlamydia pneumoniae in carotid artery atherosclerosis: a comparison of its presence in atherosclerotic plaque, healthy vessels, and circulating leukocytes from the same individuals. Stroke 2002; 33: 2756-2761.
20. Wessely S, Mall G. No detection of Chlamydia pneumoniae in normal and atherosclerotic femoral arteries by polymerase chain reaction (PCR) - an autopsy study. Z Kardiol 2003; 92: 229-235.
21. Johnson WD, Moses J, Kipshidze N. Absence of Chlamydia pneumoniae in surgical specimens of coronary and carotid arteries by polymerase chain reaction. Cardiovasc Radiat Med 2001; 2: 221-224.
22. Daus H, Ozbek C, Saage D, Scheller B, Schieffer H. Pfreundschuh M, et al. Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation. Cardiology 1998; 90: 83-88.
23. Bishara J, Pitlik S, Kazakov A, Sahar G, Haddad M, Vojdani A, et al. Failure to detect Chlamydia pneumoniae by cell culture and polymerase chain reaction in major arteries of 93 patients with atherosclerosis. Eur J Clin Microbiol Infect Dis 2003; 22: 300-302.
24. Watt S, Aesch B, Lanotte P, Tranquart F, Quentin R. Viral and bacterial DNA in carotid atherosclerotic lesions. Eur J Clin Microbiol Infect Dis 2003; 22: 99-105.
25. Vainio K, Vengen O, Hoel T, Fremstad H, Anestad G. Failure to detect Chlamydia pneumoniae in aortic valves and peripheral blood mononuclear cells from patients undergoing aortic valve replacement in Norway. Scand J Infect Dis 2002; 34: 660-663.
26. Ong GM, Coyle PV, Barros D'Sa AA, McCluggage WG, Duprex WP, O'Neill HJ, et al. Non-detection of Chlamydia species in carotid atheroma using generic primers by nested PCR in a population with a high prevalence of Chlamydia pneumoniae antibody. BMC Infect Dis 2001; 1: 12.
27. Peric M, Sagic D, Miric M, Bojic M. Angiographic characteristics of the internal thoracic artery-anatomic variations and their surgical importance. Med Pregl 2000; 53: 245-249.
28. Kobayashi H. The internal mammary artery as a graft material for coronary artery bypass surgery. Histopathologic and biochemical studies of its atherosclerotic changes. Nippon Geka Gakkai Zasshi 1990; 91: 889-900.
29. Bamford KB, Lutton DA, O'Loughlin B, Coulter WA, Collins JS. Nested primers improve sensitivity in the detection of Helicobacter pylori by the polymerase chain reaction. J Infect 1998; 36: 105-110.
30. Apfalter P, Blasi F, Boman J, Gaydos CA, Kundi M, Maass M, et al. Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens. J Clin Microbiol 2001; 39: 519-524.
31. Mahony JB, Chong S, Coombes BK, Smieja M, Petrich A. Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells. J Clin Microbiol 2000; 38: 2622-2627.
32. Abdelmouttaleb I, Danchin N, Ilardo C, Aimone-Gastin I, Angioi M, Lozniewski A, et al. C-reactive protein and coronary artery disease: Additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J 1999; 137: 346-351.
33. Torzewski J, Torzewski M, Bowyer DE, Frohlich M, Koenig W, Waltenberger J, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 1998; 18: 1386-1392.
34. Zhang YX, Cliff WJ, Shoefl GI, Higgins G. Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis 1999; 145: 375-379.
35. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000; 321: 199-204.
36. Battaille R, Klein B. C-reactive protein levels as a direct indicator of interleukin 6 levels in humans in vitro. Arthritis Rheum 1992; 35: 982-984.
37. Rodel J, Woytas M, Groh A, Schmidt KH, Hartman M, Lehmann M, et al. Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with human Chlamydia pneumoniae. Infect Immun 2000; 68: 3635-3641.
38. Berger M, Schroder B, Daeschlein G, Schneider W, Busjahn A, Buchwalow I, et al. Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes. J Lab Clin Med 2000; 136: 194-200.
39. Sniderman AD, Keech FA, Van Lennep JER, Frohlich J, Jungner I, Walldius G. Apolipoproteins versus lipids as indices of coronary and as targets for statin treatment. Lancet 2003; 361: 777-780.
40. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001;358: 2026-2033.
41. Haidari M, Moghadam M, Chinicar M, Ahmadieh A, Doosti M. Apolipoprotein B as the best predictor of coronary artery disease in Iranian normolipidemic patients. Clin Biochem 2001; 34: 149-155.
42. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312: 1061-1065.
43. Laurila A, Blougi A, Nayha S, Hassi J, Leinonen M, Saikku P. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 1999; 142: 207-210.